Anne H. van der Spek

Anne H. van der Spek

Auto-generated profile, based on publicly available information

Anne H. van der Spek

Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
ASAnne H. van der Spek
Anne H. van der Spek
EFEric Fliers
Eric Fliers
ABAnita Boelen
Anita Boelen

1 February 2010 in Life Sciences
Verified
Journal Article
Closed access
JLJacqueline M. Lankelma
Jacqueline M. Lankelma
DVDaniëlle M. Voorend
Daniëlle M. Voorend
TBTemo Barwari
Temo Barwari
JKJoris Koetsveld
Joris Koetsveld
ASAnne H. Van der Spek
Anne H. Van der Spek
CNCornelis J.F. Van Noorden
Cornelis J.F. Van Noorden

1 February 2017 in Journal of Endocrinology
Verified
Journal Article
Closed access
PDF file
ASAnne H van der Spek
Anne H van der Spek
EFEric Fliers
Eric Fliers
ABAnita Boelen
Anita Boelen
Thyroid hormone (TH) metabolism and thyroid status have been linked to various aspects of the immune response. There is extensive literature available on the effects of thyroid hormone on innate immune cells. However, only recently have authors begun to study the mechanisms behind these effects and the role of intracellular TH metabolism in innate immune cell function during inflammation. This review provides an overview of the molecular machinery of intracellular TH metabolism present in neutrophils, macrophages and dendritic cells and the role and effects of intracellular TH metabolism in these cells. Circulating TH levels have a profound effect on neutrophil, macrophage and dendritic cell function. In general, increased TH levels result in an amplification of the pro-inflammatory response of these cells. The mechanisms behind these effects include both genomic and non-genomic effects of TH. Besides a pro-inflammatory effect induced by extracellular TH, the cellular response to pro-inflammatory stimuli appears to be dependent on functional intracellular TH metabolism. This is illustrated by the fact that the deiodinase enzymes and in some cell types also thyroid hormone receptors appear to be crucial for adequate innate immune cell function. This overview of the literature suggests that TH metabolism plays an important role in the host defence against infection through the modulation of innate immune cell function.

2 August 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
JBJ H Duncan Bassett
J H Duncan Bassett
AGApostolos Gogakos
Apostolos Gogakos
JWJacqueline K White
Jacqueline K White
HEHolly Evans
Holly Evans
RJRichard Jacques
Richard Jacques
GWGraham R Williams
Graham R Williams
Osteoporosis is a common polygenic disease and global healthcare priority but its genetic basis remains largely unknown. We report a high-throughput multi-parameter phenotype screen to identify functionally significant skeletal phenotypes in mice generated by the Wellcome Trust Sanger Institute Mouse Genetics Project and discover novel genes that may be involved in the pathogenesis of osteoporosis. The integrated use of primary phenotype data with quantitative x-ray microradiography, micro-computed tomography, statistical approaches and biomechanical testing in 100 unselected knockout mouse strains identified nine new genetic determinants of bone mass and strength. These nine new genes include five whose deletion results in low bone mass and four whose deletion results in high bone mass. None of the nine genes have been implicated previously in skeletal disorders and detailed analysis of the biomechanical consequences of their deletion revealed a novel functional classification of bone structure and strength. The organ-specific and disease-focused strategy described in this study can be applied to any biological system or tractable polygenic disease, thus providing a general basis to define gene function in a system-specific manner. Application of the approach to diseases affecting other physiological systems will help to realize the full potential of the International Mouse Phenotyping Consortium. Chronic disease represents a global healthcare burden but its genetic basis is largely unknown. To address this, a massive international investment is generating a resource of mutant mice to investigate the function of every gene. Although current characterization of mutants is broadbased, it lacks specificity. Here, we describe a new and rapid functional screening approach to identify genes involved in disease susceptibility. Using bone and osteoporosis as a paradigm, we identify nine new genes that determine bone structure and strength from a screen of 100 knockout mice. Deletion of five of the genes leads to low bone mass, whereas deletion of four results in high bone mass. We also report a novel functional classification that relates bone structure to bone strength and opens the field to collaborative research between material scientists, bioengineers and biologists. Our rapid throughput phenotyping approach can be applied to complex diseases in other physiological systems, thus realizing the full potential of the International Mouse Phenotyping Consortium.

10 April 2018 in Endocrinology
Verified
Journal Article
Closed access
PDF file
ASAnne H van der Spek
Anne H van der Spek
OSOlga V Surovtseva
Olga V Surovtseva
KJKin Ki Jim
Kin Ki Jim
AOAdri van Oudenaren
Adri van Oudenaren
MBMatthijs C Brouwer
Matthijs C Brouwer
ABAnita Boelen
Anita Boelen
Innate immune cells, including macrophages, have recently been identified as novel target cells for thyroid hormone. We hypothesized that optimal intracellular concentrations of the active thyroid hormone triiodothyronine (T3) are essential for pro-inflammatory macrophage function. T3 is generated intracellularly by type 2 deiodinase (D2) and acts via the nuclear thyroid hormone receptor (TR). In zebrafish embryos, D2 knockdown increased mortality during pneumococcal meningitis. Primary murine D2KO macrophages exhibited impaired phagocytosis and partially reduced cytokine response to stimulation with bacterial endotoxin. These effects are presumably due to reduced intracellular T3 availability. Knockdown of the main TR in macrophages, TRα, impaired polarization into pro-inflammatory (M(LPS+IFNγ)) macrophages and amplified polarization into immunomodulatory (M(IL-4)) macrophages. Intracellular T3 availability and action appear to play a crucial role in macrophage function. Our data suggest that low intracellular T3 action has an anti-inflammatory effect, possibly due to an effect on macrophage polarization mediated via the TRα. This study provides important novel insights into the link between the endocrine and innate immune system.

1 September 2015 in Endocrinology
Verified
Journal Article
Open access
PDF file
JBJ. H. Duncan Bassett
J. H. Duncan Bassett
ASAnne van der Spek
Anne van der Spek
JLJohn G. Logan
John G. Logan
AGApostolos Gogakos
Apostolos Gogakos
JBJayashree Bagchi-Chakraborty
Jayashree Bagchi-Chakraborty
GWGraham R. Williams
Graham R. Williams
The ancestral glycoprotein hormone thyrostimulin is a heterodimer of unique glycoprotein hormone subunit alpha (GPA)2 and glycoprotein hormone subunit beta (GPB)5 subunits with high affinity for the TSH receptor. Transgenic overexpression of GPB5 in mice results in cranial abnormalities, but the role of thyrostimulin in bone remains unknown. We hypothesized that thyrostimulin exerts paracrine actions in bone and determined: 1) GPA2 and GPB5 expression in osteoblasts and osteoclasts, 2) the skeletal consequences of thyrostimulin deficiency in GPB5 knockout (KO) mice, and 3) osteoblast and osteoclast responses to thyrostimulin treatment. Gpa2 and Gpb5 expression was identified in the newborn skeleton but declined rapidly thereafter. GPA2 and GPB5 mRNAs were also expressed in primary osteoblasts and osteoclasts at varying concentrations. Juvenile thyrostimulin-deficient mice had increased bone volume and mineralization as a result of increased osteoblastic bone formation. However, thyrostimulin failed to induce a canonical cAMP response or activate the noncanonical Akt, ERK, or mitogen-activated protein kinase (P38) signaling pathways in primary calvarial or bone marrow stromal cell-derived osteoblasts. Furthermore, thyrostimulin did not directly inhibit osteoblast proliferation, differentiation or mineralization in vitro. These studies identify thyrostimulin as a negative but indirect regulator of osteoblastic bone formation during skeletal development.